Investigating subregional PD-L1 expression within primary tumors to predict clinical outcomes in advanced NSCLC patients who received ICB-based therapy.
Saved in:
| Title: | Investigating subregional PD-L1 expression within primary tumors to predict clinical outcomes in advanced NSCLC patients who received ICB-based therapy. |
|---|---|
| Authors: | Zhou D; Department of Respiratory and Critical Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China., Zhu Z; Department of Respiratory and Critical Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China., Mao J; Department of Respiratory and Critical Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China., Su M; Department of Respiratory and Critical Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China., Chen C; Department of Respiratory and Critical Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Oct 17; Vol. 15, pp. 1497279. Date of Electronic Publication: 2025 Oct 17 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1497279 |
